Clinical trials involving 469 adults demonstrated its efficacy in treating moderate to severe OSA, particularly in individuals with obesity
Throughout 20242025, major biotech deals reshaped the landscape: Roche/Zealand (Dec 2024) A Reuters report announced Roche would pay $1.65B upfront (up to $5.3B including milestones) for rights to Zealand Pharmas amylin analog petrelintide , testing in obesity ( [13] )
Additionally, topiroxostat inhibits the ATP-binding cassette transporter G2 (ABCG2), which plays a key role in renal uric acid reabsorption and the secretion of uric acid from the intestines
Maintaining consistent, protein-rich meals helps stabilize blood sugar and supports neurotransmitter synthesis
Pregnancy and Breastfeeding : GLP-1 medications are not recommended for anyone pregnant, planning pregnancy, or breastfeeding